A. Topitz

521 total citations
18 papers, 374 citations indexed

About

A. Topitz is a scholar working on Psychiatry and Mental health, Clinical Psychology and Social Psychology. According to data from OpenAlex, A. Topitz has authored 18 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 8 papers in Clinical Psychology and 4 papers in Social Psychology. Recurrent topics in A. Topitz's work include Schizophrenia research and treatment (5 papers), Psychosomatic Disorders and Their Treatments (4 papers) and Mental Health Treatment and Access (4 papers). A. Topitz is often cited by papers focused on Schizophrenia research and treatment (5 papers), Psychosomatic Disorders and Their Treatments (4 papers) and Mental Health Treatment and Access (4 papers). A. Topitz collaborates with scholars based in Austria, Germany and Slovenia. A. Topitz's co-authors include B. Küfferle, Thomas Brücke, S. Wenger, P. Angelberger, I. Podreka, Ch. Müller, L. Deecke, P. Anderer, B. Saletu and P Földes and has published in prestigious journals such as Journal of Cerebral Blood Flow & Metabolism, Journal of Affective Disorders and Schizophrenia Research.

In The Last Decade

A. Topitz

17 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Topitz Austria 8 137 92 87 83 75 18 374
Philip Leite Ribeiro Brazil 5 64 0.5× 64 0.7× 95 1.1× 42 0.5× 44 0.6× 6 331
Elias K. Shaya United States 9 88 0.6× 217 2.4× 90 1.0× 80 1.0× 42 0.6× 13 448
Débora Pastore Bassitt Brazil 12 231 1.7× 34 0.4× 141 1.6× 54 0.7× 44 0.6× 22 456
Killian A. Welch United Kingdom 9 104 0.8× 67 0.7× 99 1.1× 25 0.3× 41 0.5× 11 318
J. E. Jääskeläinen Finland 8 168 1.2× 144 1.6× 23 0.3× 146 1.8× 47 0.6× 8 436
Christie L. McGee United States 11 74 0.5× 46 0.5× 46 0.5× 55 0.7× 73 1.0× 13 1.3k
Jeffrey Lieberman United States 9 170 1.2× 61 0.7× 107 1.2× 25 0.3× 51 0.7× 21 432
Stephen I. Kramer United States 7 211 1.5× 33 0.4× 84 1.0× 64 0.8× 87 1.2× 15 395
Nicole Crocker United States 11 103 0.8× 30 0.3× 64 0.7× 31 0.4× 55 0.7× 11 1.0k
Irene Hurford United States 8 301 2.2× 40 0.4× 127 1.5× 51 0.6× 62 0.8× 15 454

Countries citing papers authored by A. Topitz

Since Specialization
Citations

This map shows the geographic impact of A. Topitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Topitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Topitz more than expected).

Fields of papers citing papers by A. Topitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Topitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Topitz. The network helps show where A. Topitz may publish in the future.

Co-authorship network of co-authors of A. Topitz

This figure shows the co-authorship network connecting the top 25 collaborators of A. Topitz. A scholar is included among the top collaborators of A. Topitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Topitz. A. Topitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Niederkrotenthaler, Thomas, Josef Baumgärtner, Alexander Kautzky, et al.. (2021). Effects of media stories featuring coping with suicidal crises on psychiatric patients: Randomized controlled trial. European Psychiatry. 64(1). e70–e70. 3 indexed citations
2.
Dahlbender, Reiner W., et al.. (2016). Kreuzvalidierung von drei Fragebögen zur Strukturdiagnostik: BPI, IPO und OPD-SF. Zeitschrift für psychosomatische Medizin und Psychotherapie. 62(2). 177–189. 17 indexed citations
3.
Stompe, Thomas, et al.. (2016). Alkohol- und Drogenmissbrauch bei psychisch kranken PatientInnen mit Migrationshintergrund in Österreich. Neuropsychiatrie. 30(3). 138–144. 1 indexed citations
4.
Topitz, A., et al.. (2015). Prävalenz und Erkennen der Depression an nicht-psychiatrischen Krankenhausabteilungen. Neuropsychiatrie. 29(2). 63–70. 7 indexed citations
5.
Freidl, Marion, Peter Berger, A. Topitz, et al.. (2015). Schmerzsymptome als Hinweis auf Depressionen und Angsterkrankungen bei PatientInnen an somatischen Krankenhausabteilungen. Psychiatrische Praxis. 43(5). 273–278. 3 indexed citations
6.
Berger, Patrick, Ingrid Sibitz, Marion Freidl, A. Topitz, & H. Katschnig. (2011). The reliability of a brief diagnostic interview, the trips, for the assessment of psychiatric disorders according to ICD-10 in primary care and non-psychiatric medical settings. European Psychiatry. 26(S2). 867–867. 1 indexed citations
7.
Sibitz, Ingrid, Peter Berger, Marion Freidl, et al.. (2010). ICD-10 or DSM-IV? Anhedonia, fatigue and depressed mood as screening symptoms for diagnosing a current depressive episode in physically ill patients in general hospital. Journal of Affective Disorders. 126(1-2). 245–251. 23 indexed citations
8.
Ortner, Romana, et al.. (2001). [Cocaine abuse in maintenance therapy with methadone in narcotic dependent patients].. PubMed. 113(23-24). 934–8. 5 indexed citations
9.
Fischer, Gabriele, et al.. (1999). Pregnancy and substance abuse. Archives of Women s Mental Health. 2(2). 57–65. 22 indexed citations
10.
Saletu, B., et al.. (1994). Clinical, EEG Mapping and Psychometric Studies in Negative Schizophrenia: Comparative Trials with Amisulpride and Fluphenazine. Neuropsychobiology. 29(3). 125–135. 56 indexed citations
11.
Schanda, Hans, et al.. (1992). Premorbid adjustment of schizophrenic criminal offenders. Acta Psychiatrica Scandinavica. 86(2). 121–126. 32 indexed citations
12.
Brücke, Thomas, I. Podreka, P. Angelberger, et al.. (1991). Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders. Journal of Cerebral Blood Flow & Metabolism. 11(2). 220–228. 155 indexed citations
13.
Saletu, B., B. Küfferle, J Grünberger, P Földes, & A. Topitz. (1991). Clinical, brain mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine. European Neuropsychopharmacology. 1(3). 473–473. 1 indexed citations
14.
Meszaros, K., et al.. (1991). A carbamazepine augmentation trial in chronic nonresponsive schizophrenia. Schizophrenia Research. 4(3). 291–291. 1 indexed citations
15.
Küfferle, B., et al.. (1990). Smooth Pursuit Eye Movements in Schizophrenia: Influences of Neuroleptic Treatment and the Question of Specificity. Psychopathology. 23(2). 106–114. 21 indexed citations
16.
Thau, K., et al.. (1989). Computerized Documentation for Lithium Outpatients (Routine and Research Data). Pharmacopsychiatry. 22(2). 76–80. 3 indexed citations
17.
Thau, K., et al.. (1988). Effect of Lithium on the EEG of Healthy Males and Females. Neuropsychobiology. 20(3). 158–163. 22 indexed citations
18.
Topitz, A.. (1964). [ON THE CHARACTERISTICS OF CENTRAL EUROPEAN HEAT WAVE PERIODS].. PubMed. 114. 217–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026